17
Participants
Start Date
March 31, 2016
Primary Completion Date
November 15, 2022
Study Completion Date
July 26, 2023
Thymoglobulin
0.5 mg/kg IV over 6 hours on day -9 and 2 mg/kg IV over 4 hours on day -8 and day -7 with premeds and solumedrol through day -2
Cyclophosphamide
14.5 mg/kg IV over 1 hour day -6 and -5 50 mg/kg IV over 2 hours with mesna 40 mg/kg IV day +2 and +3
Fludarabine
30 mg/m2 IV over 60 minutes days -6 through day -2
Total Body Irradiation
See arm description for dosing.
Bone marrow infusion
Bone marrow infusion on Day 0
Tacrolimus
Day +5 through day +100 with goals of 5-10 ug/L (not used for HLA-identical related donors). When used in non-MSD recipients, tapered over 6-8 weeks starting at day +100.
Mycophenolate Mofetil
15 mg/kg IV q8h (based upon actual body weight) with the maximum total daily dose not to exceed 3 grams. Day +5 through day 35
Donor mesenchymal stem cell infusions
Day 60, 100 and 180 (collected during donor BM harvest for graft)
Busulfan
busulfan IV over 3 hours on days -3 and -2 for HLA-mismatched BM recipients only (Arms F and G)
University of Minnesota Masonic Cancer Center and Medical Center, Minneapolis
Masonic Cancer Center, University of Minnesota
OTHER